disease-free survival
Additionally, the study evaluates treatment response, overall survival (OS), and disease-free survival (DFS) in patients treated with the GRAALL 2005 protocol combined with Tyrosine Kinase Inhibitors (TKI).
Additionally, the study evaluates treatment response, overall survival ( OS ), and disease-free survival ( DFS ) in patients treated with the GRAALL 2005 protocol combined with Tyrosine Kinase Inhibitors ( TKI ) .